Series: Pragmatic trials and real world evidence: Paper 2. Setting, sites, and investigator selection

Abstract
No abstract available
Funding Information
  • European Federation of Pharmaceutical Industries and Associations
  • Seventh Framework Programme (FP7/2007/2013)
  • Innovative Medicines Initiative (115546)